Vr Adviser, LLC Oric Pharmaceuticals, Inc. Transaction History
Vr Adviser, LLC
- $414 Million
- Q1 2025
A detailed history of Vr Adviser, LLC transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Vr Adviser, LLC holds 3,182,527 shares of ORIC stock, worth $15.1 Million. This represents 4.29% of its overall portfolio holdings.
Number of Shares
3,182,527
Previous 4,394,527
27.58%
Holding current value
$15.1 Million
Previous $35.5 Million
49.93%
% of portfolio
4.29%
Previous 5.85%
Shares
4 transactions
Others Institutions Holding ORIC
# of Institutions
144Shares Held
75.4MCall Options Held
11.3KPut Options Held
2.7K-
Viking Global Investors LP6.57MShares$31.3 Million0.12% of portfolio
-
Nextech Invest, Ltd. Zurich, V85.29MShares$25.2 Million6.85% of portfolio
-
Nextech Invest Ag5.29MShares$25.2 Million7.95% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$23 Million0.0% of portfolio
-
Alkeon Capital Management LLC New York, NY4MShares$19.1 Million0.05% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $188M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...